Amiodarone (n = 11) | Control (n = 15) | p-values | |
---|---|---|---|
Age, years (mean ± SD) | 67.2 ± 7.5 | 71.7 ± 6.5 | 0.100 |
Men/Women, n | 4/7 | 6/9 | 0.851 |
Cardiovascular comorbidity, n | – | ||
Valvular heart disease | 8 | 13 | |
Ischemic heart disease | 1 | 0 | |
Thoracic aortic aneurysm | 1 | 0 | |
Aortic dissection | 0 | 1 | |
Aortic dissection + Ischemic heart disease | 1 | 0 | |
Valvular heart disease + Ischemic heart disease | 0 | 1 | |
Warfarin indication (preoperative), n | – | ||
Atrial fibrillation | 4 | 11 | |
Post prosthetic valve replacement | 4 | 4 | |
Low LVEF | 3 | 0 | |
Dosage of warfarin (baseline), mg/day (mean ± SD) | 2.64 ± 0.89 | 3.07 ± 1.22 | 0.370 |
PT-INR value (baseline) (mean ± SD) | 2.13 ± 0.58 | 2.27 ± 0.58 | 0.551 |